Ardelyx (ARDX) Net Cash Flow (2013 - 2026)
Ardelyx (ARDX) posted Net Cash Flow of -$36.8 million for Q1 2026, down 245.51% on a QoQ basis from $25.3 million in Q4 2025, and down 7.81% year-over-year from -$39.9 million in Q1 2025.
Ardelyx (ARDX) Net Cash Flow (2013 - 2026) Analysis & Trends
Ardelyx's Net Cash Flow history runs 14 years deep, the most recent figure standing at -$36.8 million for Q1 2026.
- Quarterly Net Cash Flow fell 7.81% year-over-year to -$36.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $401000.0 (up 107.51% YoY) and the FY2025 annual result came in at $3.1 million, down 92.94% from the prior year.
- Net Cash Flow was -$36.8 million for Q1 2026 at Ardelyx, down from $25.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $59.2 million in Q2 2025 and bottomed at -$62.4 million in Q2 2023.
- A 5-year average of -$2.4 million and a median of $5.5 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow soared 1306.71% — and 2023, when it tumbled 1086.08%.
- Ardelyx's Net Cash Flow stood at $34.5 million in 2022, then plunged by 135.63% to -$12.3 million in 2023, then soared by 242.34% to $17.5 million in 2024, then jumped by 44.46% to $25.3 million in 2025, then sank by 245.51% to -$36.8 million in 2026.
- Business Quant data shows ARDX's Net Cash Flow at -$36.8 million in Q1 2026, $25.3 million in Q4 2025, and -$47.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -36.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.79 Mn |
| Mar 31, 2026 | -36.79 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Mar 31, 2025 | -34.12 Mn |
| Mar 31, 2025 | -34.12 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | -12.30 Mn |
| Dec 31, 2023 | -12.30 Mn |